#14026
Re: Novavax (NVAX): Un Nuevo Comienzo
Pfizer y BioNTech concluyen el estudio de fase 3 de la vacuna candidata COVID-19, que cumple con todos los criterios de valoración principales de eficacia
https://www.businesswire.com/news/home/20201118005595/en/
The observed efficacy in adults over 65 years of age was over 94%.
The observed efficacy in adults over 65 years of age was over 94%.